PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 52 filers reported holding PMV PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,819 | +11.0% | 3,065 | +13.1% | 0.00% | – |
| Q2 2023 | $16,958 | -21.5% | 2,709 | -40.2% | 0.00% | – |
| Q1 2023 | $21,608 | +218.8% | 4,530 | +481.5% | 0.00% | – |
| Q4 2022 | $6,777 | -99.9% | 779 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $9,200,000 | -16.5% | 773,096 | +0.0% | 0.00% | 0.0% |
| Q2 2022 | $11,016,000 | +18.6% | 773,051 | +73.3% | 0.00% | 0.0% |
| Q1 2022 | $9,288,000 | -20.0% | 446,119 | -11.3% | 0.00% | 0.0% |
| Q4 2021 | $11,612,000 | -40.5% | 502,700 | -23.2% | 0.00% | -50.0% |
| Q3 2021 | $19,501,000 | +7.6% | 654,400 | +23.3% | 0.00% | +100.0% |
| Q2 2021 | $18,129,000 | +30.8% | 530,714 | +25.9% | 0.00% | 0.0% |
| Q1 2021 | $13,860,000 | -46.6% | 421,400 | -0.2% | 0.00% | -50.0% |
| Q4 2020 | $25,970,000 | +77.9% | 422,200 | +2.7% | 0.00% | +100.0% |
| Q3 2020 | $14,598,000 | – | 411,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |